The latest missive in the dietary supplement industry and US regulators’ dispute about using N-acetyl-L-cysteine as a dietary ingredient doesn’t resolve their differences, but it makes clear a program is needed to keep track of the players and the score.
The Council for Responsible Nutrition’s 4 January comment to the Food and Drug Administration also brings to the forefront that not only is the agency taking an unprecedented path toward summarily deeming N-acetyl-L-cysteine, an amino acid commonly identified as NAC, disqualified for use as a
The CRN’s letter responds to the FDA Center for Food Safety and Applied Nutrition’s November response to the trade group’s citizen petition – docket